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Abstract
Naïve and primed pluripotent hESCs bear transcriptional similarity to pre- and post-implantation 
epiblast and thus constitute a developmental model for understanding the earliest pluripotent 
stages in human embryo development. To identify new transcription factors that differentially 
regulate the unique pluripotent stages, we mapped open chromatin using ATAC-Seq and found 
enrichment of the AP2 transcription factor binding motif at naïve-specific open chromatin. We 
determined that the AP2 family member TFAP2C is upregulated during primed to naïve reversion 
and becomes widespread at naïve-specific enhancers. TFAP2C functions to maintain pluripotency 
and repress neuroectodermal differentiation during the transition from primed to naïve by 
facilitating the opening of enhancers proximal to pluripotency factors. Additionally, we identify a 
previously undiscovered naïve-specific POU5F1 (OCT4) enhancer enriched for TFAP2C binding. 
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Taken together, TFAP2C establishes and maintains naïve human pluripotency and regulates OCT4 
expression by mechanisms that are distinct from mouse.
Introduction
The broad contours of pre-implantation development are conserved between mice and 
humans1. After fertilization to create the zygote, the embryo undergoes cell divisions, 
compacts to form the morula, then undergoes further cell division and cavitation to form the 
fluid-filled blastocyst. At this point, the first three cell types, trophoblast, primitive 
endoderm, and epiblast are specified, with the epiblast destined to give rise to all embryonic 
tissues. Upon implantation, the epiblast undergoes dramatic changes in gene expression and 
epigenetic state, “priming” it to differentiate rapidly in response to external cues. As such 
the epiblast transitions from the naive pluripotent state to the primed pluripotent state. 
Gastrulation then occurs and pluripotency is lost altogether.
Despite this similar overall program, it has become clear that there are dramatic molecular 
differences between mouse and human embryo development2–8. However, given the 
significant limitations in research using human embryos, it has not been possible to 
rigorously compare the murine and human naïve epiblast.
In humans, the traditional approach for deriving and culturing human ESCs (hESCs) from 
pre-implantation embryos results in cells with primed pluripotency similar to EpiSCs. 
However, new media formulations for transitioning or deriving hESCs in the naïve state have 
now been developed9,10. Critically, naïve hESCs largely recapitulate the transcriptional and 
epigenetic program of human pre-implantation epiblast cells6,11,12. Therefore, naïve and 
primed hESCs are the only human cell-based models for understanding the critical fate 
transition between naïve and primed pluripotency in the human embryo and the contrast 
between murine and human epiblast.
Results
AP2-motifs are strongly enriched in naïve-specific regulatory elements
To identify transcription factors critical for naïve human pluripotency, we mapped open 
chromatin using assay for transposase-accessible chromatin (ATAC-seq13) in naïve and 
primed hESCs (Supplementary Figure 1A, Supplementary Table 1). Cells were cultured in 5 
inhibitors plus LIF, Activin A, and FGF2 (5iLAF) to recapitulate the naïve state and with 
FGF2 and Knockout serum replacement media (KSR) to recapitulate the primed state9,12. As 
expected, we observed strong enrichment of open chromatin at gene promoters 
(Supplementary Figure 1B), with enrichment associating with gene expression. We defined 
sets of ATAC-seq peaks in naïve and primed hESCs, as well as peaks specific to either the 
naïve or primed states (Supplementary Figure 1C, Supplementary Table 2, and Materials and 
Methods). While all sets showed enrichment of promoter sequence, this enrichment was 
much weaker for naïve and primed-specific open sites (Supplementary Figure 1C), 
consistent with the general trend that enhancer utilization rather than promoter openness is 
more variable between different cell types14,15.
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Broadly, we observed a strong correlation between the appearance of naive-specific ATAC-
seq peaks near a gene, and up-regulation of that gene in the naïve state, and between the 
appearance of a primed-specific ATAC peak near a gene and down-regulation in the naïve 
state (Figure 1A,B, Supplementary Figure 1D,E). This was true whether the ATAC-peak was 
upstream or downstream of the gene TSS (Supplementary Figure 1E,F). For example, naïve-
specific ATAC peaks are observed in the vicinity of the naïve-specific Krupple life factor 5 
(KLF5) while, primed-specific ATAC-seq peaks are observed in the vicinity of the primed-
specific genes ZIC2 and ZIC5 (Figure 1C,D). These observations are consistent with a high 
proportion of ATAC-seq peaks corresponding to enhancers that regulate nearby genes. 
Comparison to published ChIP-seq data in naïve and primed hESCs16 revealed enrichment 
of Mediator over naïve and primed specific ATAC-seq peaks in the corresponding cell type, 
and we observed strong enrichment of H3K27Ac at the boundaries of these peaks, with a dip 
in the middle likely explained by nucleosome depletion (Figure 1E). Mediator and 
H3K27Ac enrichment are predictive features of active enhancers17,18, further validating the 
ATAC-seq peaks as regulatory elements.
To identify transcription factors critical for the activity of enhancers in the naïve and primed 
states, we determined enrichment of known transcription factor binding motifs in the naïve 
and primed-specific ATAC peaks (Figure 1F, G)19. The strongest statistical enrichment in the 
naïve state corresponded to the KLF motif, consistent with the strong up-regulation of KLF 
family factors in naïve hESCs and the known role for KLF in naïve-state pluripotency in 
mouse and human9,10,20. Likewise, the motif of the primed-specific21 ZIC factors was 
enriched in the primed peaks. Unexpectedly, very strong enrichment for the AP2 
transcription factor motif was observed for naïve-specific open chromatin. AP2 transcription 
factors have been implicated in a number of developmental processes in mice, including 
placental development22–24, neural crest development25 and ectodermal patterning25–27, but 
are completely dispensable for murine epiblast formation and mouse pluripotent cell 
survival22–24,28. Hence, there may be a human-specific role for an AP2 factor in the naïve 
state.
Naïve-specific regulatory elements are present in vivo
To determine the in vivo relevance of our set of naïve-specific ATAC peaks, we performed 
ATAC-seq on eight pooled pre-implantation human blastocysts (Supplementary Table 3). We 
found dramatically increased openness in the human blastocyst over naïve-specific peaks, 
both relative to surrounding sequence and relative to primed peaks (Figure 2A–C, 
Supplementary Figure 2A), validating the biological relevance of these peaks. Nonetheless, 
there were marked differences between the open chromatin patterns in whole blastocyst and 
naïve hESCs. We reasoned that this was because the day 6 human blastocyst consists 
primarily of trophoblast, with a much smaller fraction of epiblast and hypoblast29. For 
example, we found that blastocyst showed lower ATAC-seq enrichment in the vicinity of the 
epiblast-specific gene Nanog but higher enrichment in the vicinity of the trophoblast-specific 
GATA3 (Figure 2D,E). This trend was apparent when we plotted ATAC-enrichment over 
epiblast and trophoblast-specific gene bodies as defined from published RNA-seq data 
(Figure 2F,G).
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We found AP2 and KLF motifs strongly enriched in blastocyst and naïve hESC chromatin, 
consistent with reported activation of AP2 and KLF-family transcription factors in morula 
and continued expression in human epiblast and trophoblast (Figure 2H,I). GATA TF motif 
was strongly enriched in blastocyst-specific chromatin while OCT4-SOX2 motif was 
strongly enriched in naïve and primed hESCs, consistent with preferential expression of 
GATA2 and GATA3 in the trophoblast and OCT4 in the inner cell mass and epiblast. Our 
data thus strongly support the idea that naïve hESCs have an open chromatin state similar to 
pre-implantation epiblast.
Using an alternate approach we further confirmed the in vivo relevance of the naïve-specific 
ATAC peaks by analyzing DNA methylation, given that regulatory elements are typically 
hypomethylated relative to surrounding sequence30,31. Consistent with this trend, we 
observe strong hypomethylation of naïve-specific ATAC-seq peaks in naïve hESCs cultured 
in 5iLAF or in t2iLGö10, a different culture method for generating naive hESCs6,12 
(Supplementary Figure 2B). Likewise, we observe a more pronounced drop in DNA 
methylation between the oocyte and blastocyst stages of human embryonic development at 
our defined set of naïve-specific ATAC peaks than over surrounding sequence or primed-
specific ATAC peaks (Supplementary Figure 2C,D). Thus, multiple lines of evidence support 
the proposition that the majority of putative regulatory elements identified in naive hESCs 
correspond to a hypomethylated regulatory element in human pre-implantation embryos.
TFAP2C supports reversion to the human naïve state
Of the five AP2-family transcription factors present in humans, only TFAP2C is highly 
expressed in the naïve state (Figure 3A). TFAP2C is upregulated in naïve cells at both the 
RNA and protein level (Figure 3A, B) and is expressed in human morula and pre-
implantation epiblast3,8,32. ChIP for TFAP2C showed strong enrichment over naïve-specific 
ATAC-seq peaks (Figure 3C, D), especially those containing AP2 motifs (Figure 3D). 
Furthermore, TFAP2C showed stronger enrichment at naïve-specific ATAC-seq peaks than 
at regions open in both the primed and naïve state (Figure 3E), even though both ATAC peak 
sets show similar ATAC-seq enrichment in the naïve cells (Figure 3F). Combined with our 
observation that AP2-motifs are specifically enriched in naïve-specific peaks, this data 
indicates that TFAP2C may facilitates the opening of regulatory elements during reversion.
We used CRISPR to target TFAP2C in the primed state, and lines containing null mutations 
of both alleles were confirmed karyotypically normal (Supplementary Figure 3A, B). In the 
primed state these lines showed normal expression of pluripotency genes and markers 
(Supplementary Figure 3C–F). The TFAP2C−/− cells were able to exit pluripotency normally 
with spontaneous embryoid body (EB) differentiation and showed a skew toward neural 
lineage, consistent with a known role for TFAP2C in regulating the formation of neural vs. 
non-neural ectoderm27 (Supplementary Figure 3G).
Upon reversion in naïve 5iLAF media, we observed a dramatic morphological change in the 
TFAP2C−/− hESC lines (Figure 4A, Supplementary Figure 4A, B). Consistent with this 
rapidly-emerging phenotype we discovered that at day 3 of reversion, TFAP2C protein is 
strongly induced in the control cells, while being absent in the TFAP2C−/− lines (Figure 4B, 
C). TFAP2C ChIP and ATAC-seq at day 5 of reversion shows opening of naïve-specific 
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enhancers and enrichment of TFAP2C at these sites but no opening of these enhancers in 
TFAP2C−/− (Figure 4D,E). Initially, the TFAP2C−/− cells divided rapidly in 5iLAF, but after 
one passage, round naïve-like colonies were identified only in controls (Figure 4A). Instead, 
sparse clusters of small cells were observed in the TFAP2C−/− lines after the first passage 
that ceased to divide and disappeared from culture. By day 5 of reversion, the TFAP2C−/− 
cells showed dramatic loss of pluripotency factors and upregulation of neural lineage factors 
(Figure 4F–J), a result confirmed by GO-analysis33 (Supplementary Figure 4C). Likewise 
ATAC-seq showed a loss of AP2 and pluripotency transcription factor motifs in open 
chromatin in the TFAP2C−/− cells after five days of reversion and instead, a gain of peaks 
enriched for motifs related to neural development such as SOX and ZIC (Supplementary 
Figure 4D, E).
To confirm that this finding was human specific, we performed ATAC-seq on mESCs 
cultured in the naïve state (2i+LIF) as well as primed Epiblast Like cells (EpiLCs)34 
(Supplementary Table 4). We discovered that AP2 sites were enriched in naïve-specific open 
chromatin in 2i + LIF mESCs. However, the degree of enrichment was far lower than human 
naïve cells (Figure 4K, L). We generated Tfap2c−/− and Tfap2a−/−Tfap2c−/− mESCs 
(Supplmentary Figure 4F,G) and found normal expression of pluripotency markers in 2i+LIF 
(Figure 4M). Furthermore, comparing ATAC-seq in control and Tfap2a−/−Tfap2c−/− double 
knockout mESCs, we found only 373 control-specific ATAC-seq peaks, and this set was 
only moderately enriched for AP2 sites (Figure 4N). Thus, AP2 transcription factors play a 
more modest role in murine than human naïve states.
Withdrawal of TFAP2C in naïve state causes shift toward primed state
Next, we generated a TFAP2C−/− mutant line capable of expressing TFAP2C in a 
doxycycline-dose dependent manner (Figure 5A). Overexpression of TFAP2C in primed 
media did not result in a pronounced shift toward naïve-gene expression, and TFAP2C 
primarily honed to regions of chromatin that were already open in primed hESCs 
(Supplementary Figure 5A,B), arguing that the combinatorial activity of multiple factors is 
necessary for primed to naïve reversion.
We then reverted the TFAP2C−/− Dox-inducible line, using 5iLAF media supplemented with 
various quantities of doxycycline. Induction of TFAP2C rescued the morphological 
abnormality observed in the mutant, preserved OCT4 expression, repressed SOX1 induction, 
and allowed formation of colonies with naïve-morphology (Figure 5B–E, Supplementary 
Figure 5C).
To determine the effect of acute loss of TFAP2C, we cultured cells in 5iLAF + doxycycline 
until naïve morphology colonies were apparent, then switched to media without 
doxycycline. No acute phenotype was observed, instead a gradual loss of cells from culture 
occurred (Supplementary Figure 5D,E). Cells remaining 12 days after doxycycline 
withdrawal showed increased staining for the primed surface marker SSEA4 and closing of 
naïve-specific ATAC peaks, especially the subset containing AP2 sites but no KLF sites 
(Figure 5F, Supplementary Figure 5F). These findings indicate that TFAP2C is essential for 
maintenance as well as establishment of the naïve state.
Pastor et al. Page 5
Nat Cell Biol. Author manuscript; available in PMC 2018 October 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
TFAP2C−/− in low O2
Because low oxygen conditions can stabilize the pluripotent state and promote human 
embryogenesis35, we conducted two independent reversions in 5% oxygen. Similar to the 
results obtained with reversions under ambient (~20%), morphological differences, loss of 
OCT4, and gain of SOX1 and PAX6 were all apparent upon culture in 5iLAF in 5% O2 
(Figure 6A,B, Supplementary Figure 6A). However, approximately two weeks after onset of 
culture in 5iLAF under 5% O2 conditions, round colonies appeared in the TFAP2C−/− 
cultures and these putative colonies were capable of self-renewal (Figure 6B, Supplementary 
Figure 6A). However, almost all TFAP2C−/− cells had high SSEA4 surface expression 
(Figure 6A), consistent with primed identity 12. The second reversion featured a substantial 
population of cells with SSEA4 negative identity, but these cells showed gain of neural and 
loss of pluripotency markers, indicating that they were differentiated rather than naive (see 
RPKM in Supplementary Table 5). ATAC-seq of TFAP2C−/− cells persisting in 5iLAF under 
5% O2 showed reduced openness over naïve-specific peaks, and increased openness over 
primed-specific ATAC-seq peaks compared with controls (Figure 6C). Moreover, principle 
component analysis of the ATAC-Seq data sets showed a closer similarity to primed cells 
(Figure 6D), with the transcriptome of the persisting TFAP2C−/− cells present in 5% O2 
shifted toward expression of primed-specific genes (Figure 6E, Supplementary Figures 
6B,C). In further support of the finding that persistent TFAP2C−/− colonies in 5% O2 are 
more primed-like, we compared the RNA-Seq to published primate RNA-seq6 and found a 
global reduction in genes specific to pre-implantation epiblast and an increase in genes 
specific to post-implantation epiblast (Supplementary Figures 6D,E). Finally, we reverted 
the TFAP2C−/− in t2iLGöY naïve media36 in 5% O2, and similar to the results in 5iLAF, the 
TFAP2C−/− cells lacked nuclear KLF17, a marker of naïve cells (Supplementary Figure 6F, 
G). In total, these data support an essential role for TFAP2C in reversion of primed hESCs to 
the human naïve state.
TFAP2C promotes expression of pluripotency genes
The simple presence of a transcription factor at a locus does not prove a role in regulating 
nearby genes, and we observe 14,367 distinct TFAP2C peaks throughout the genome (Figure 
7A,B), making it difficult to discern which binding events are important for gene regulation. 
Compared with the striking correlation observed between presence of a naïve-specific 
enhancer and upregulation of a nearby gene (Figure 1A), we observed only a modest 
correlation between the presence of a TFAP2C ChIP-peak near a gene and the up-regulation 
of that gene in the naïve state or downregulation in TFAP2C−/− (Figure 7A). To the extent an 
effect was discernable, the presence of a TFAP2C peak at an enhancer adjacent to the gene 
was predictive of upregulation in the naïve state, but the presence of a TFAP2C peak at a 
gene TSS had a very little effect on the expression of that gene, which was surprising given 
that the promoter is a key site of gene regulation.
We therefore sought to identify direct targets of TFAP2C by combining RNA-seq, ATAC-seq 
and ChIP-seq data. First, we looked at the set of genes specific to the naïve or primed state 
and focused on the subset that showed >4-fold changes in expression in TFAP2C−/− (Figure 
7C). Second, we defined a set of TFAP2C-dependent regulatory elements: TFAP2C ChIP-
seq peaks that overlapped with naïve-specific ATAC-peaks and showed reduced openness in 
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TFAP2C−/− (Figure 7D,E). We found an extremely strong relationship between 
downregulation of a gene in TFAP2C−/− and the presence of a TFAP2C-dependent 
regulatory element nearby (Figure 7F, Supplementary Table 6). The vast majority of 
TFAP2C-dependent regulatory elements did not overlap with a gene TSS and were thus 
likely to be enhancers rather than promoters (Figure 7G). By contrast, TFAP2C ChIP-seq 
peaks in regions of openness conserved between naïve and primed state, had virtually no 
predictive effect on gene expression in TFAP2C−/− (Supplementary Figure 7A,B). In other 
words, TFAP2C’s primary effect in naïve hESCs is most likely to open a discreet set of 
regulatory elements, mainly enhancers (Figure 7H).
GREAT analysis37 showed that genes within 50kb of a TFAP2C-dependent regulatory 
element were upregulated in Theiller stage 3 and 4 embryos (morula and early blastocyst) 
and that mutations of these genes were associated with abnormal embryogenesis 
(Supplementary Tables 6,7). Adjacent genes included CBFA2T2, TFCP2L1, KLF5, SOX2, 
FGF4, NANOG, DPPA3, DPPA5 and TFAP2C itself (Figure 7I, Supplementary Figure 7C–
E, Supplementary Table 7), supporting a role for TFAP2C in directly promoting the naïve 
pluripotent program.
An intronic enhancer for OCT4 is active in naïve hESCs
One of the characteristic properties that distinguishes naive and primed states is different 
enhancer utilization at POU5F1 (OCT4). In mouse, the proximal enhancer upstream of 
POU5F1 is critical for expression in the post-implantation epiblast while the distal enhancer 
farther upstream drives expression in primordial germ cells and ICM38. In human pre-
implantation blastocyst however, neither enhancer appears open, whereas two putative 
enhancers appear downstream of the POU5F1 TSS (Figure 8A). Each of these peaks 
contains a cluster of AP2 sites and a KLF site, indicating that they could be opened by the 
combinatorial activity of these transcription factors during pre-implantation development 
(Figure 8B). “Intron element 1” shows evolutionary conservation across placental mammals 
(Supplementary Figure 8A) and is open and enriched for TFAP2C in naïve hESCs (Figure 
8A,B) but is not open in naïve mESC (Figure 8C). We do not observe any reads emanating 
from this element spliced into the OCT4 transcript, ruling out the possibility that it is 
actually an alternative promoter (Supplementary Figure 8B). Furthermore, we observe 
enhancer activity for this region in a luciferase assay, which is largely eliminated by the loss 
of either the AP2 or KLF site (Figure 8D).
To examine the role of this enhancer in naïve pluripotency, we ablated this sequence using 
CRISPR/Cas9 and confirmed normal karyotype (Figure 8B, Supplementary Figure 8C). We 
found normal expression of OCT4 (Supplementary Figure 8D) and self-renewal in the 
primed state, but a dramatic loss of OCT4 expression accompanied by differentiation upon 
reversion to the naïve state (Figure 8E,F). This indicates a potential direct role for TFAP2C 
in regulating the pluripotency master-regulator OCT4 by binding to a previously unknown 
enhancer, which in turn is likely to be important for pre-implantation OCT4 expression.
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Discussion
We present strong evidence that TFAP2C is critical for the opening of a set of enhancers in 
naïve hESCs. Furthermore, we show that most of these enhancers are present in human 
embryo and therefore biologically relevant, and likely to directly regulate genes critical for 
human naïve pluripotency.
TFAP2C has been implicated in both activation and repression of target loci39–41, which 
may explain the limited effect of TFAP2C at promoters where it is already present. However, 
the enrichment of AP2 motifs in naïve-specific ATAC-peaks, the failure of many of these 
enhancers to open in the absence of TFAP2C, and the strong association between TFAP2C-
dependent enhancers and expression of nearby genes is indicative of a critical role for 
TFAP2C in regulating gene expression by opening enhancers. TFAP2C is known to interact 
with members of the CITED family of proteins, which in turn recruit the histone 
acetyltransferase p30042–44, suggesting a model in which TFAP2C facilities enhancer 
opening by promoting histone acetylation. Because TFAP2C is expressed in the morula 
before blastocyst formation, it could have a role in resetting the chromatin landscape prior to 
the establishment of naïve pluripotency, analogous to what happens in the artificial system 
of in vitro reversion.
The observation that TFAP2C is critical in naïve hESCs in vitro would lead us to predict that 
TFAP2C is critical for gene regulation in pre-implantation epiblast in vivo. This is surprising 
in light of results in mouse, where TFAP2C is clearly dispensable for ICM and epiblast 
specification. Tfap2c homozygous null mice develop to the blastocyst stage22–24, as do 
mutants generated using Tfap2cfl/fl Zp3-Cre in which the maternal Tfap2c transcript is 
absent23. Tfap2c deficient mESCs have been successfully derived from embryos22,28 and 
generate viable mice in tetraploid complementation22, indicating that the gene is non-
essential in ICM. Redundancy with other AP2 factors is unlikely to explain this non-
essential role, as Tfap2a−/− Tfap2c−/− double mutant embryos also develop an epiblast, and 
the other AP2 factors are expressed at very low levels in morula and blastocyst23. The major 
role for Tfap2c in mouse pre-implantation embryo development is specification and 
differentiation of trophoblast, with Tfap2c null mutant mice dying from placental defects45. 
Notably, while Tfap2c is strongly enriched in the trophoblast relative to ICM in mouse 
blastocysts, human ICM and pre-implantation epiblast retain high levels of TFAP2C3,8,32. 
Tfap2c has also been reported in porcine ICM46, indicating that loss of Tfap2c from the 
ICM may be specific to mice. TFAP2C direct targets in human embryos include both genes 
general to pre-implantation embryo as well as genes specific to epiblast such as CBFA2T2, 
FGF4, and MEG3.
TFAP2C-dependent regulation of OCT4 may also be different in mouse and human, as is 
role of OCT4 itself. In mice, OCT4 is essential for pluripotency and for repression of 
trophoblast genes in the ICM47. CRISPR ablation of OCT4 in human embryos by contrast 
results in outright failure to form blastocyst or express genes associated with trophoblast or 
epiblast lineage48. Thus, OCT4 plays an essential role in humans as early as morula. Our 
data are consistent with a model in which OCT4 expression is initially regulated by TFAP2C 
and KLF family TFs via the intronic enhancers and only later is regulated from the naïve-
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specific distal enhancer. However, alternative possibilities cannot be ruled out, such as the 
distal enhancer being active in morula and decommissioned in trophoblast, which makes up 
the bulk of early blastocyst.
Morphological and molecular evidence supports the phenomenon of the “developmental 
hourglass”, the idea that the developmental program is actually most evolutionarily 
conserved in mid-embryogenesis, and both early and late stages of development feature high 
levels of variation across different species49,50. The discovery of a human-specific naïve 
pluripotency factor fits into this paradigm, and therefore model organisms may only reveal 
some of the story of how human embryos develop.
Methods
Human cell culture
Culture of primed and naïve hESCs, and reversion from primed to naïve state, were 
conducted as previously reported12, the only modification being the inclusion of 1x 
Primocin (Invivogen) in all medias. All cells were cultured in 5% CO2 and ambient oxygen 
unless otherwise indicated. Where indicated, doxycycline was added.
The reversion of primed hESCs to naïve t2iLGöY state was performed as previously 
described36, generating the t2iLGöY media as described in a previous report51. All cell lines 
were cultured in a 37°C, 5% O2 and 5% CO2 for the t2iLGöY reversion experiments.
Murine Cell culture
During routine passage and CRISPR editing, murine ESCs were cultured in Serum+LIF 
media: 15% Hyclone FBS (ThermoFisher), 1x Penicillin/Streptomycin/Glutamine 
(ThermoFisher), 1x Non-essential amino acids (ThermoFisher), 55μM β–mercaptoethanol 
(ThermoFisher), 1xPrimocin (Invivogen) and 1000U/mL ESGRO LIF (Millipore) in 
KnockOut DMEM (ThermoFisher). Cells were passaged with 0.25% Trypsin every three 
days and cultured on MEFs. Prior to all RNA-seq or ATAC-seq experiments, cells were 
cultured for at least five passages in 2i+LIF media: 1x N2 supplement, 1xB27 supplement, 
1x Penicillin/Streptomycin/Glutamine (ThermoFisher), 1x Non-essential amino acids 
(ThermoFisher), 55μM β–mercaptoethanol (ThermoFisher), 1xPrimocin (Invivogen), 3μM 
CHIR99021 (Stemgent), 0.5μM PD0325901 (Stemgent) and 1000U/mL ESGRO LIF 
(Millipore) in a 50%/50% mixture of DMEM/F12 without HEPES (ThermoFisher) and 
Neurobasal media (ThermoFisher). Cells passaged in 2i+LIF were passaged every three days 
with 0.25% trypsin and plated at 50k cells/well onto wells pretreated with poly-L-Ornithine 
(Sigma) and Laminin.
Murine EpiSCs were a gift from P. Tesar and were cultured in Primed hESC media12. 
EpiSCs were passaged with 1xCollagenase Type IV (Life Technologies) every three days.
Collecting cell populations for sequencing experiments
For sorting primed and naïve hESCs in steady state for RNA-seq and ATAC-seq TRA-1-85+ 
SSEA4+ and TRA-1-85+ SSEA4− cells were sorted as previously described12. For the first 
replicate of RNA-seq from day 5 reversion cells, MEFs were removed by twice plating the 
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cells for five minutes on a gelatinized plate to allow MEFs to attach, but for the second 
replicate of RNA-seq and for ATAC-seq, MEFs were removed by sorting for all TRA-1-85+ 
cells. The isolated human cells were then processed for sequencing as discussed below
To separate mESCs or EpiLCs from MEFs, cells were detached with 1xTrypsin, quenched 
and then washed with 1xFACS buffer, stained with 1:150 anti-SSEA1 in 1xFACS buffer, 
then washed and stained with DAPI immediately prior to sort. SSEA1+ SSClo DAPI− cells 
were sorted and then used for RNA-seq or ATAC-seq.
For human or murine ChIP experiments, cells were harvested using Accutase, quenched, and 
washed with 1xPBS prior to fixation.
Embryoid body differentiation
Primed human embryonic stem cells 7 days after plating were washed with 1xPBS and 
treated with 1xCollagenase Type IV at 37°C for 1hr, then removed from the plate with short 
strokes by a cells scraper. 4mL of MEF media (see above) was added to the well and the 
colonies were allowed to settle in a 50mL conical tube. Media was then aspirated by pipet, 
and the cells were resuspended in 3mL mTESR media with ROCKi and plated in a low 
attachment 6-well plate. At the 24 hour time point, the EBs were transferred into a 50mL 
conical tube and allowed to settle. Media was removed and replaced with primed hESC 
media12 lacking FGF. Media was changed again at hour 72 and the embryoid bodies were 
harvested at the 144 hour timepoint.
Embryo isolation and generation
Day 6 vitrified blastocysts were thawed using Vit Kit-Thaw (Irvine Scientific) according to 
manufacturer protocol. Embryos were cultured in drops of Continuous Single Culture media 
(Irvine Scientific) supplemented with 20% Serum Substitute Supplement (Irvine Scientific) 
under mineral oil for 2–3 hours at 37°C, 6% CO2 and 5% O2. Embryos with good 
morphology were used for ATAC-seq.
Targeting of loci with guide RNA
Guide RNA were designed using crispr.mit.edu. The highest scoring appropriately situated 
gDNA sequences were used, with bases removed from the 5’end as necessary so that the 
guide RNA sequence started with the base “G”. Human TFAP2C was targeted with the 
guide sequence GCTTAAATGCCTCGTTAC. The Human OCT4 intronic enhancer was 
targeted with the guides GGCACCCCTTGTAGAAAGC and 
GTAATGAGTGACCAGACCCT. Murine TFAP2C was targeted with the guide sequence 
GTTACTTTGTACTTCGACG. Murine TFAP2A was targeted with 
GGGACTATCGGCGGCACG.
CRISPR Editing of hESCs
UCLA1 hESCs52 were cultured at least two passages in mTESR1 media (StemCell 
Technologies) on Matrigel (Corning). Cells in exponential growth phase were harvested with 
Accutase, and 800k hESCs were electroporated with 4μg plasmid DNA using the CA-137, 
Primary Cell 3 program in the Amaxa 4-D Nucleofector X-subunit (Lonza). After 
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transfection, cells were transferred to a single well of a 24-well plate containing primed 
hESC media (see above) supplemented with 1x Y-27632 (Stemgent). Prior to transferring 
the electroporated cells, the 24-well plate was coated with gelatin and with MEFs. The 
hESCs were cultured in MEFs in all later steps.
For generation of the TFAP2C deficient hESC lines, cells were passaged with Accutase and 
plated on 10cm plates for colony picking the day after transfection. This resulted in 
heterogenous colonies, probably because CRISPR-mediated cleavage continued after single 
cells were plated for colony-picking, requiring later subcloning. Pure TFAP2C−/− lines were 
only generated later by subcloning. The OCT4 Intronic Enhancer line was plated with on 
10cm plates three days after transfection, and did not require later subcloning.
To obtain clonal and physically separate colonies, cells were harvested with Accutase and 
10k cells were plated on 10cm plates to allow physically separated colonies to grow. Cells 
were fed with primed hESC media starting two days after plating and media was 
subsequently changed every day. Nine to 11 days after plating, colonies were scored with a 
syringe and the pieces were transferred to a 24-well plate, where they were allowed to grow 
an additional 6–7 days in primed hESC media. Cells were then split with Accutase. Two 
thirds of the material was used for DNA extraction and screening (see Screening for 
mutations below), the remaining third was plated in primed hESC media with ROCKi in a 
well of a 12-well plate. After two days, media was changed to primed hESC media without 
ROCKi and the cells were passaged using normal primed conditions described above in the 
cell culture subsection above.
For the TFAP2C−/− lines, a further round of colony picking, expansion and genotyping was 
conducted to generate pure knockout populations. Both TFAP2C−/−Lines 1 and 2 were 
generated from the same round of transfection of UCLA1 hESCs. Control Line 1 was 
generated by transfection of UCLA1 hESCs with pMaxGFP plasmid and no CRISPR 
construct, with cloning and subcloning performed in parallel.
CRISPR Editing of mESCs
Murine ESCs were plated the day before transfection at a density of 150k cells per well in a 
6-well plate for each transfection sample. On day of transfection, cells were harvested with 
trypsin, precipitate, and then resuspended in 2.5mL of serum+LIF media (see above).
In a separate tube, 5μg of DNA (1.43μg GFP plasmid + 3.57μg CAS9/gDNA construct, 5μg 
GFP plasmid for controls) was diluted to 375μL with Opti-MEM media (ThermoFisher). In 
another separate tube 12.5μL of Lipofectamine 2000 (ThermoFisher) was combined with 
375μL Opti-MEM. The Lipofectamine/Opti-MEM solution was incubated 5 minutes, 
combined with the DNA solution, and incubated a further 20 minutes at room temperature. 
The DNA/Lipofectamine/Opti-MEM mix was added to the suspended cells and the cells 
were rotated for 4 hours at 37°C. The transfected cells were then spun down, resuspended in 
fresh serum+LIF media, and plated on MEFs.
After 48 hours, cells were harvested with Trypsin and GFP+ cells were sorted and cultured 
in 96-well plates on MEFs. Three days after sorting, media was changed. Six days after 
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sorting, wells with colonies were split with trypsin and split onto 24-well plates with MEFs. 
After another three days, cells were split again, with 12.5% of the cells split onto a 24-well 
plate with MEFs to propagate the line, 25% split onto a gelatin-treated plate without MEFs 
to grow cells for DNA extraction, and the rest frozen to create stocks. After another three 
days, the cells on gelatin were harvested for DNA extraction.
To obtain pure clonal population, the targeted mESCs were later subcloned by sorting for 
individual SSEA1+ cells and plated.
Screening for mutations
DNA was extracted using the Quick gDNA Miniprep kit and the region containing the 
targeted allele was amplified by PCR. To screen human TFAP2C−/− and murine TFAP2C−/− 
and TFAP2A−/− TFAP2C−/− mutant lines, the Surveyor Mutant Detection Kit (IDT) was 
used to identify point mutants, though some point mutations in the murine lines were large 
enough to be apparent by agarose electrophoresis even without Surveyor cutting. For 
targeting of the OCT4 Naïve Enhancer, mutant alleles were identified based on the reduced 
size of the targeted region.
To determine the identity of the mutations and confirm clonality of the targeted lines, several 
strategies were undertaken. First, bulk PCR product was subjected to Sanger sequencing, to 
determine if there was any visible trace from WT product. Second, PCR product was cloned 
into the TopoTA vector and at least eight clones sequenced to identify the mutations in both 
alleles and confirm no WT allele. Third, for human TFAP2C−/− and murine Tfap2c−/− lack 
of protein was confirmed by Western blot. For the OCT4 Intron element targeting, clonal 
deletion was also confirmed both by the lack of a WT-sized band in the initial screening 
PCR and by the failure to amplify with primers internal to the deleted region.
Generation of Doxycycline inducible line
TFAP2C was cloned into a construct facilitating expression under a doxycycline inducible 
(tetON) promoter, followed by an auto-cleaving “2A” linker and Red Fluorescent Protein 
(RFP) to allow detection. This tetON-TFAP2C-2A-RFP construct was made by cloning 
TFAP2C-2A-RFP to replace the hNANOG in FUW-tetO-lox-hNANOG (Addgene 60849). 
VSVG coated lentiviruses including tetON-TFAP2C-2A-RFP and FUW-lox-M2rtTA were 
generated in HEK293T cells. TFAP2C mutant line 1 hESCs were treated with Accutase to 
make single cell suspension in 100uL hESC media with ROCKi with 100,000 single cells. 
Cells were transduced with 1:1 ratio of tetON-TFAP2C-2A-RFP and FUW-lox-M2rtTA and 
plated in 10cM dishes at different concentrations. Individual colonies were picked and 
genotyped for tetON-TFAP2C-2A-RFP and FUW-lox-M2rtTA.
Reporter assay
The OCT4 intronic enhancer (hg19 chr6 31,137,269-31,137,697) was amplified and cloned 
into pGL3 Promoter vector (Promega). Versions with the three AP2 sites (hg19 
31,137,370-31,137,378, 31,137,529-31,137,537 and 31,137,547-31,137,555) or KLF site 
(hg19 31,137,477-31,137,485) deleted were synthesized by Genewiz and cloned into pGL3. 
200,000 naïve UCLA19n (first replicate) or UCLA20n (second replicate) hESCs were then 
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transfected with 800ng of either empty pGL3 promoter vector or one of the three constructs 
described above, along with 200ng of pRL-TK Renilla vector as a transfection efficiency 
control. We used Amaxa nucleofection with P3 buffer and the program CA-137 and plated 
the cells onto a 12-well plate well of MEFs. The cells were then detached from the well with 
Accutase and lysed, and luminescence was detected using the Dual-Glo Luciferase system 
(Promega).
Immunostaining
For Figures 4I and J, immunofluorescence was conducted as published12, with using anti-
TFAP2C (SantaCruz 8977, 1:100), anti-OCT4 (sc8628-X, 1:100), anti-PAX6 (R&D Systems 
AF3369, 1:100). For Supplementary Figure 6F, immunostaining was performed as 
previously described51. Primary antibodies used: rabbit anti-KLF17 polyclonal (1:500, 
Sigma HPA024629), mouse anti-TRA-1-60 IgM (1:300, BD), and secondary antibodies 
used: goat anti-rabbit IgG AF555 secondary (1:400, ThermoFisher), goat anti-mouse IgM 
AF488 secondary (1:400, ThermoFisher).
Western blotting
Western blots and quantitation with the Odyssey Infrared Imager (Licor) were conducted as 
described previously12. Antibodies used include anti-OCT4 (SantaCruz sc8628), NANOG 
(R&D Systems AF1997), TFAP2C (SantaCruz sc8977 and Abcam ab76007), SOX1 (R&D 
Systems AF3369), SOX2 (R&D Systems AF2018), PAX6 (R&D Systems AF2085). 
Western signals were normalized to signal from anti-H3 antibody (Abcam ab10799 or 
Abcam ab1791). All antibodies were used at concentrations of 1:1000 except Santa Cruz 
anti-TFAP2C (1:700) and H3 (1:3000).
RNA isolation and library generation
RNA was isolated using the RNeasy Mini Kit (Qiagen). 5ng to 50ng total RNA input was 
used to generate sequencing libraries using the Ovation Ultralow Library System V2 
(Nugen) and then Ovation Rapid Library System (Nugen) protocols.
ATAC-seq library preparation
In all experiments using cultured cells, between 25k and 50k sorted cells were subjected to 
ATAC-seq as previously reported53. To perform ATAC-seq on embryos, the embryos were 
incubated in the reported ATAC-seq lysis buffer for ten minutes, during which they were 
vortexed for ten seconds every three to four minutes, after which the protocol was conducted 
identically to the previous report.
ChIP protocol and library generation
Cells were fixed with 1% paraformaldehyde (Sigma) and incubated with rotation for 10 
minutes at room temperature. The paraformaldehyde was quenched by adding glycine to a 
final concentration of 0.14M and rotated another 10 minutes at room temperature. The cells 
were then centrifuged 735g for 5 minutes and then flash frozen with liquid nitrogen and 
stored at −80°C until ChIP was conducted.
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To lyse the cells for ChIP, cells were thawed and resuspended with 1mL lysis buffer (10mM 
TrisHCl pH 8.0, 0.25% Triton X-100, 10mM EDTA, 0.5mM EGTA, 1x Protease inhibitors 
(Roche) and 1mM PMSF), then rotated 15 minutes. Nuclei were pelleted by centrifugation 
at 1500g for 5 minutes at 4°C. Nuclei were then resuspended with 1mL 10mM TrisHCl pH 
8.0, 200mM NaCl, 10mM EDTA, 0.5mM EGTA, 1x Protease inhibitor, 1mM PMSF and 
rotated 10 minutes. Nuclei were then pelleted and resuspended in 650μL 10mM TrisHCl pH 
8.0, 10mM EDTA, 0.5mM EGTA,1x Protease inhibitor, 1mM PMSF and sonicated in a 
12mm × 12mm Sonication Tube (Covaris) in a Covaris S2 (Intensity = 5; Cycles/burst = 
200; Duty Cycle = 5%; 8× (30″ on/30″ off) for four minutes effective sonication). The 
sonicated lysate is then centrifuged for 10 minutes at 14200g, and the supernatant retained. 
10% of the supernatant is saved as “Input”, the rest is used for ChIP.
30μL of Protein A Dynabeads (ThermoFisher) are washed three times with ChIP buffer 
(16.7mM TrisHCl pH 8.0, 0.01% SDS, 1.1 Triton X-100, 1.2mM EDTA, 167mM NaCl), 
each wash consisting of addition of 1mL of buffer and collection of the beads on a magnetic 
rack (Diagenode). The 30uL of beads were then resuspended in 650μL of ChIP buffer and 
combined with the ChIP sample to pre-Clear the sample. Beads and chromatin were rotated 
2hrs at 4°C, and the beads were collected and the supernatant retained. 3μL of anti-TFAP2C 
antibody (sc-8977) was added to the ChIP sample. The samples were then rotated overnight 
at 4°C.
60μL of Protein A Dynabeads were then added to the ChIP samples and rotated 2 hours at 
4°C. The beads were then washed 2×4 minutes with 500μL Wash Buffer A (50mM HEPES 
pH 7.9, 1% TritonX-100, 0.1% Deoxycholate, 1mM EDTA, 140mM NaCl), 500μL Wash 
Buffer B (50m HEPES pH 7.9, 0.1% SDS, 1% Triton X100, 0.1% Deoxycholate, 1mM 
EDTA, 500mM NaCl), and 500μL TE buffer (10mM TrisHCl pH 8.0, 1mM EDTA). Each 
wash consists of resuspension in 500μL buffer and rotation at 4 minutes, followed by 
collection of beads and removal of supernatant. DNA was eluted in 100μL elution buffer 
(50mM TrisHCl pH 8.0, 1mM EDTA, 1% SDS) at 65°C for 10 minutes in a ThermoMixer 
(Eppendorf) shaking at 1400RPM. The eluent was collected and the beads were subjected to 
a second round of elution with 150μL elution buffer
The ChIP eluants were pooled, and the input sample was diluted to 250μL with elution 
buffer. These samples was incubated 65°C overnight to promote decrosslinking. The 
samples were then allowed to cool to room temperature, 15μg of RNAse A (Purelink, 
ThermoFisher) was added, and the samples were incubated 30 minutes at 37°C to degrade 
RNA. 100 μg Proteinase K was then added and the samples were incubated 56°C for two 
hours. DNA was purified using a MinElute PCR Purification kit (Qiagen).
DNA was sonicated again to 150bp average fragment size with a Covaris S2, concentrated 
with Agencourt AMPure XP beads (Beckman Coulter) and libraries were generated using 
the Ovation Ultralow Library System V2 (Nugen).
Replicates and data pooling
All replicates are listed in Supplementary Table 1 and are biological replicates except where 
otherwise noted. For determination of ChIP or ATAC-seq peaks or display of ChIP or ATAC 
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data in figures, all reads from a given condition (e.g. d5 human ATAC-seq control samples) 
were merged to increase coverage. RNA-seq reads for a given condition were merged when 
comparing RPKM across conditions or analyzing splicing but were considered separately 
when calculating differentially expressed genes (see RNA-seq data analysis below).
RNA-seq data analysis
RNAseq data was mapped to hg19 using Tophat54 and read counts per gene were determined 
using HTSeq55 as previously described12. Differentially expressed genes were calculated 
using DESeq56, and RPKM values were calculated with a custom script. Once differential 
expressed genes were determined, they were analyzed for GO terms were called using 
GOrilla, which calculates p-values and q-values using a hypergeometric test33.
Correlation between changes in gene expression and proximity of ATAC and ChIP peaks 
was also calculated by a custom script.
ATAC-seq data analysis
ATAC-seq data was mapped using Bowtie as previously described53. Peaks were defined in 
each condition using MACS2 callpeaks tool57 with appropriate genome size. To find peaks 
specific to one condition (e.g. Naïve Specific), we use the predictd module of MACS2 to 
determine predicted extension size of each data set being compared, callpeaks for each 
dataset the –B and –- no model options and with the extension size specified as the average 
of the two samples, and the bgddiff module using the generated pileup and lambda files with 
the options –g 60 –l 120. An eight-fold relative enrichment cutoff was used to define peaks 
specific to each state, except when comparing murine WT and Tfap2a−/− Tfap2c−/−, in 
which a six-fold cutoff was used due to the relatively small number of peaks different in the 
two conditions.
To identify peaks in common between the primed and naïve states, and overlap between 
different peak sets, we used the Bedtools intersect tool58.
ChIP-seq data analysis
ChIP-seq data was mapped using Bowtie2 with default settings and clonal reads were 
removed using samtools rmdup. Reads from all replicates for a given condition were merged 
and peaks were using MACS2 callpeaks57, comparing ChIP against input reads and using 
appropriate genome size and default settings. To determine overlap with ATAC-seq peaks, 
we used the bedtools intersect tool58.
Motif Analysis
Enriched motifs in peak sets were identified using the HOMER findMotifsGenome tool with 
appropriate genome and default settings19.
Principal component analysis
For principal component analysis (PCA) for RNA-seq data, RPKM for each sample were 
used as input. Variance of each gene’s RPKM in different samples were then calculated 
(rowVars function in R). PCA analysis (prcomp function in R) was performed on genes with 
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the top 1000 variance across samples. PCA plot were then plotted with ggplot2 package in R 
(http://ggplot2.org).
For principal component analysis (PCA) for ATAC-seq data, peaks of in each ATAC-seq 
samples were first defined with MACS2(v.2.1.1) with default parameters. Then, ATAC-seq 
peaks cross all samples were merged into one union ATAC-seq peak set and ATAC-seq reads 
in each sample were calculated over the union ATAC-seq peak set. ATAC-seq reads in 
different samples were then normalized over its sequencing depth and this matrix is used as 
input for PCA analysis. Variance of normalized ATAC-seq reads over each peak were then 
calculated (rowVars function in R). PCA analysis (prcomp function in R) was performed on 
peaks with the top 1000 variance across samples. PCA were then plotted with ggplot2 
package in R (http://ggplot2.org).
Analysis of peak location
Annotation of peak location (Promoter, intragenic, intergenic etc.) and calculation of 
distance to nearest promoter was calculated using HOMER annotatepeaks tool with the 
appropriate genome19.
GREAT Analysis
We used GREAT analysis37 calling genes near the midpoints of the TFAPC dependent 
regulatory elements. We instructed the program to use the two nearest genes to the peaks, 
provided they are within 50kb of the peak. GREAT calculates p and q values using a 
binomial test, as well as a hypergeometric test for comparison37.
Reverse Transcription and real-time PCR
For Figure 8E, real time PCR was perfomed as described59. For Supplementary Figure 6G, 
RNA extraction and cDNA synthesis were performed as described previously51, RT-PCR 
was carried out on the 7500 Real-Time PCR system (ThermoFisher). TaqMan probes used: 
ACTB: Hs01060665_g1 (ThermoFisher) and KLF17: Hs00703004_s1 (ThermoFisher).
Alterations to images
Overall brightness of some brightfield microscopy images was increased to improve 
visibility, and Supplementary Figure 5C was converted to grayscale to improve visibility.
Animal work
MEFs were derived following UCLA institutional animal care and use committee (IACUC) 
approval.
Embryo donation
Use of human embryos in this research project followed California State law, which required 
review by two committees, the Institutional Review Board (IRB) and the human embryonic 
stem cell research oversight committee (ESCRO), which approved the process of informed 
consent, and experiments using human embryos for research purposes. Following approval 
and outreach to fertility clinics with a flyer advertising the study, individuals and couples 
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with stored frozen IVF embryos contacted us to donate surplus embryos either through 
referral or through initiating contact with the UCLA Broad Stem Cell Research Center. 
Patients were not paid for participation, and all donors were informed that the embryos 
would be destroyed as part of the research study. Participants were also informed that they 
could withdraw consent at any time and if the embryos had been shipped to UCLA, they 
would be destroyed. Participants were also informed that donated embryos would not be 
used to make a baby. All research with human embryos in this study complied with the 
principles laid out in the International Society for Stem Cell Research guidelines.
Statistics and reproducibility
Statistical analysis was performed using existing programs (MACS257, Homer19, DESeq56, 
GOrilla33). Mean and standard error were calculated using standard statistical formulas. 
Where the ratio of expression for two sets is shown, as in Figures 4H, 4M, and 5E, standard 
error is calculated by the formula SE(quotient) =quotient*SQRT((SE(Set1)/Mean(Set1))^2+ 
(SE(Set2)/Mean(Set2))^2).
The observation that TFAP2C is upregulated at the protein level in naïve over primed cells 
(as shown in Figures 3B and 4B) was observed for Western blots generated from five 
independent lysate preparations. Induction of TFAP2C within three days of culture in 5iLAF 
(as shown in Figure 4B) was observed in two independent reversions.
The finding that TFAP2C−/− hESCs express OCT4 normally in the primed state 
(Supplementary Figure 3C) was demonstrated in Western blots from three independent 
lysate preparations, similar findings for NANOG and SOX2 (Supplementary Figures 3D, E) 
were performed once. The flow cytometry plots in Supplementary Figure 3F showing 
pluripotency surface markers on TFAP2C−/− hESCs are representative of three experiments.
The finding that TFAP2C−/− hESCs colonies showed morphological abnormality in 5iLAF 
(as shown in Figures 4A and Supplementary Figure 4 A,B) by day 5 was observed in nine 
independent reversions. Four of these reversions were continued long enough to confirm loss 
of TFAP2C−/− upon prolonged culture, as shown in Figures 4A and 5D. Loss of TFAP2C in 
TFAP2C−/− mutant (as shown in Figure 4C) was shown by Western blot from five 
independent reversions and by immunofluorescence (as shown in Figure 4I) in two 
independent reversions. Loss of pluripotency factors. and gain of neural factors was shown 
in by Western blot (as shown in Figure 4F and J) in four independent reversions and by 
immunofluorescence (as shown in Figure 4I and 4J) in two independent reversions. Loss of 
Tfap2c in Tfap2C−/− murine ESCs (as shown in Supplementary Figure 4G) was confirmed 
via Western blots from two independent lysate preparations.
Rescue of the TFAP2C−/− differentiation phenotype in 5iLAF by doxycycline inducible 
TFAP2C expression (as shown in Figure 5A–D and Supplementary Figure 5C) was observed 
in four experiments. Reduced cell proliferation after withdrawal of doxycycline (as shown in 
Supplementary Figure 5D and 5E) was observed in two experiments.
Bulk differentiation of TFAP2C−/− in 5iLAF at 5% O2, with a small population maintaining 
self-renewal (as shown in Figure 6, Supplementary Figure 6) was observed in two 
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independent reversions. Loss of KLF17 in TFAP2C−/− t2iLGöY in Supplementary Figure 6F 
was demonstrated from two reversions.
The finding that OCT4 protein is expressed normally in the OCT4 ΔIntronic enhancer 
mutant, as shown in Supplementary Figure 8D, was based on one Western blot. Loss of cells 
in the OCT4 ΔIntronic enhancer mutant upon treatment with 5iLAF (as shown in Figure 8F) 
was observed in three independent reversions, with qRT-PCR data (as shown in Figure 8E) 
derived from one such reversion.
Code Availability
Custom scripts used for demultiplexing NGS reads, calculating RPKM, generating DNA 
methylation metaplots and comparing distribution of peaks to expression of nearby genes 
will be made available upon request.
Data Availability
All high throughput sequencing datasets described in Supplementary Table 1 have been 
deposited in the Gene Expression Omnibus (GEO) under the accession number GSE101074. 
RNA-seq data from naive and primed hESCs was gleaned from our previously published 
data12 (GSE76970). ChIP-seq data on H3K4me3, H3K27Ac3 and Mediator from naïve and 
primed hESCs was obtained from published sources9,16 (GSE69647). Peaks sets used in this 
paper are included in Supplmentary Tables 2 and 4, and RPKMs from RNA-seq data are 
included in Supplementary Table 5. Source data for Figures 3A, 4H, 4M, 5E and 
Supplementary Figures 3G, 5A and 6B are available in Supplementary Table 8. Additional 
data is available upon reasonable request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Determination of regulatory elements specific to the naïve and primed states in humans
a,b Percentage of the time a gene whose transcriptional start site is a given distance from a 
naïve-specific ATAC-peak (a) or primed-specific ATAC-peak (b) is upregulated or 
downregulated in the naïve state. c,d Many naïve-specific ATAC-seq peaks appear proximal 
to KLF5 (c), a gene highly upregulated in the naïve state, while primed-specific ATAC-peaks 
are present near the primed-specific ZIC genes. Note the strong enrichment of H3K27Ac 
near ATAC-seq peaks. H3K4me3 and H3K27Ac ChIP-seq data come from published 
sources9,16. e, Metaplot of H3K27Ac and Mediator over naïve-specific (left) and primed 
specific (right) ATAC-peaks. f,g Most statistically significant transcription factor binding 
motifs enriched in naïve-specific (f) or primed-specific (g) ATAC peaks were calculated 
using a cumulative binomial distribution19. Pooled data from 4 naïve and 4 primed 
biological replicates were used.
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Figure 2. Most naïve-specific ATAC-peaks are present in other naïve human cells and the human 
embryo
a, Normalized ATAC-seq reads from the human blastocyst plotted relative to Naïve-specific 
and primed-specific peaks. Note far greater enrichment over naïve-specific peaks. b, 
Blastocyst ATAC-seq plotted relative to all Naïve-specific ATAC peaks. Note enrichment 
over almost all naïve-specific peaks, indicating that they are open in the blastocyst. c, Most 
Naïve-specific ATAC-seq peaks overlap with a blastocyst-ATAC peak, but most primed-
specific peaks do not. d,e ATAC-seq signal for primed hESCs, naïve hESCs and blastocyst 
in the viscinity of NANOG (d) and GATA3 (e). Peak height is normalized to total number of 
reads in each sample. f,g Metaplot of ATAC-seq read density over the gene bodies of 100 
genes most highly specific to trophoblast or epiblast, as defined from single-cell RNA-seq 
data in human3, as well as all genes. h, Venn diagram showing overlap of all ATAC-seq 
peaks in blastocyst, naïve hESCs and primed hESCs. i, Enrichment of GATA, AP2, KLF and 
OCT-SOX motifs in each set identified in part e. Note enrichment of AP2 and KLF motifs in 
both blastocyst and naïve hESCs, stronger enrichment of GATA in blastocyst and stronger 
enrichment of OCT-SOX in ESCs.
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Figure 3. TFAP2C is highly enriched over naïve-specific open chromatin in humans
a, TFAP2C is highly expressed in naïve cells, both relative to other AP2 transcription factors 
and relative to primed cells. Mean and standard deviation are shown, with dots representing 
each replicate (n=4 independent experiments). b, TFAP2C protein is highly upregulated in 
the naïve-pluripotent state. Data represent 1 out of 5 independent experiments with similar 
results. c, Strong co-enrichment of TFAP2C with naïve-specific ATAC peaks at the 
CBFA2T2 locus. d, Global enrichment of TFAP2C relative to the summits of different 
categories of naïve-specific ATAC peaks. TFAP2C is enriched over naïve-specific ATAC 
peaks, especially those with AP2 motifs. e,f TFAP2C is strongly enriched over Naïve-
specific ATAC peak summits compared with enrichment over regions that show ATAC 
enrichment in both naïve and primed cells (Naïve-primed Intersect) (e), even though both 
peak sets show similar ATAC enrichment (f). Uncropped Western blot images are available 
in Supplementary Figure 9. Source data for a is available in Supplementary Table 8.
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Figure 4. TFAP2C−/− cells differentiate in naïve media
a, TFAP2C−/− hESCs, self-renew in primed conditions but differentiate and fail to self-
renew upon treatment in naïve (5iLAF) media. Scale bars indicate 100 μm. Data represent 1 
out of 4 independent experiments with similar results. b, Western blot of TFAP2C upon 
culture in primed or 5iLAF conditions. TFAP2C is strongly induced within three days of 
treatment with 5iLAF. Data represent 1 out of 2 independent experiments with similar 
results. c, Western blot for TFAP2C after five days of 5iLAF culture. TFAP2C is absent 
from TFAP2C−/− deficient lines. d, ATAC-seq openness of Naïve, d5 5iLAF WT and 
TFAP2C−/−, and primed cells over naïve-specific ATAC peaks. Note that after five days of 
reversion, substantial opening of the naïve-specific ATAC peaks has already occurred, but 
not in the TFAP2C−/−cells. e, TFAP2C ChIP enrichment shown over naïve and d5 5iLAF 
samples. ChIP input for each set is shown as a dashed line. f, Western blot for OCT4 and 
NANOG in control and TFAP2C−/− cells after five days of culture in 5iLAF. Quantitation 
normalized to histone below. g, Western Blot for SOX1 and PAX6 in control and TFAP2C−/− 
cells. h, Relative RPKM of pluripotency and neural markers in RNA-seq. Data is from n=3 
WT and n=4 TFAP2C−/− independent biological replicates (mean +/− s.e). i,j, 
Immunofluorescent staining for TFAP2C, OCT4 (i) and PAX6 (j) in control and TFAP2C−/− 
cells. Scale bar indicates 20 μm. k,l Fold enrichment for AP2 motifs in the specified peak 
sets in humans (k) and mouse (l). Asterix indicates no enrichment. Although AP2 motifs are 
enriched in naïve-specific peaks in both species, the enrichment is much stronger in the 
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human naïve-specific set. m, Expression of key pluripotency markers in WT, Tfap2c−/−, and 
Tfap2a−/− Tfap2c−/− cells in 2i+LIF conditions. n=4 biological replicates in for Tfap2c−/− 
and controls and n=6 biological replicates for Tfap2a−/− Tfap2c−/− and controls (mean +/− 
s.e.) n, ATAC-seq peaks specific to WT and Tfap2a−/− Tfap2c−/− were calculated and 
enrichment for AP2 motifs determined. Asterisk indicates no enrichment. Uncropped 
Western blots in Supplementary Figure 9. Source data for h and m in Supplementary Table 
8.
Pastor et al. Page 26
Nat Cell Biol. Author manuscript; available in PMC 2018 October 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. Ectopic expression of TFAP2C partially rescues TFAP2C−/− phenotype
a, Quantitative western blot showing tunable TFAP2C induction in TFAP2C−/− background 
in primed conditions. b,c Western blots show rescue of OCT4 expression and SOX1 
repression upon doxycycline inducible TFAP2C expression. Lysates were collected after five 
days of treatment with 5iLAF and the indicated concentration of doxycycline. d, Appearance 
of round naïve-like colonies in lines with ectopic TFAP2C expression. Scale bar indicates 
100μm. Results represent 1 out of 4 independent experiments with similar results. e, Partial 
rescue of upregulation of naïve pluripotency factors, downregulation of primed-factors with 
ectopic TFAP2C expression. 1 replicate for dox induction samples and primed control, 4 for 
naïve samples and primed control. f, TFAP2C was ectopically expressed for the first 15 days 
of reversion, then removed in some cells to induce acute loss of TFAP2C. ATAC-seq plotted 
from these cells is plotted over naïve-specific peaks (5032 peaks), a subset that contained an 
AP2 motif but no KLF motif (1054 peaks), a subset that contained a KLF motif but no AP2 
motif (1551 peaks) and primed-specific peaks (2562 peaks). Reduced ATAC-seq density 
over naïve specific peaks and increased density over primed-specific peaks, in the sample in 
which doxycycline had been withdrawn. Closing of naïve specific peaks is especially 
pronounced over the subset of peaks that contain AP2 sites but no KLF sites (AP2+ KLF-). 
Peaks subsets are listed in Supplementary Table 2. Uncropped Western blot images are 
available in Supplementary Figure 9. Source data for e is available in Supplementary Table 8
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Figure 6. TFAP2C−/− cells survive in 5iLAF in 5% O2 conditions but do not transition to naïve 
state
a, Western blots for the pluripotency marker OCT4 and the neural markers SOX1 and PAX6 
in WT and TFAP2C−/− cells after 5 days in 5iLAF at 5% O2. b,c Brightfield images of 
control and TFAP2C−/− cells in 5iLAF culture. Initially the TFAP2C−/− cells show 
morphology similar to what is observed in ambient oxygen concentration conditions 
(compare to Figure 4A). However, some colonies are observable after passaging. These 
colonies show a shift toward SSEA4+ (primed) state. Scale bars indicates 100μm. c, ATAC-
seq data from control and TFAP2C−/− cells in 5% O2 plotted over ATAC-seq peak sets. d, 
Principle component analysis comparing ATAC-seq datasets generated in this work. Blue 
dots: after five days in 5iLAF, WT control cells show an ATAC-seq landscape part-way 
between primed and naïve, whereas TFAP2C−/− cells show no change toward naïve. Green 
dots: although TFAP2C−/− cells survive in low oxygen conditions, they have an ATAC-seq 
landscape much more similar to primed than naïve cells. Red dots: ectopic doxycycline 
dependent-expression of TFAP2C in TFAP2C−/− partially rescues the naïve-landscape, and 
withdrawal of doxycycline induces a shift toward primed identity. Shown for comparison are 
control cells reverted at the same time. e, Genes differentially regulated in naïve vs. primed 
hESCs are plotted. Note that genes higher expressed in naïve cells are lower expressed in 
TFAP2C−/−. The RPKM values correspond to SSEA4− cells in control (average of 2 
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biological replicates) and SSEA4+ in TFAP2C−/− (average of 3 biological replicates). 
Uncropped Western blot images are available in Supplementary Figure 9.
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Figure 7. Identifying direct regulatory targets of TFAP2C
a, Percentage of the time a gene whose transcriptional start site is a given distance from a 
TFAP2C ChIP-seq peak is upregulated or downregulated in naïve hESCs. Notice the much 
weaker correspondence compared with Figure 1A, and the lack of any effect at the promoter. 
b, Distance of TFAP2C ChIP-seq peak to nearest promoter. c, To identify pluripotency-state 
genes positively or negatively regulated by TFAP2C, we identified the subset of naïve-
specific genes downregulated <4 fold in TFAP2C−/− (positively related by TFAP2C) and 
primed-specific genes upregulated >4 fold in TFAP2C−/− (negatively regulated by TFAP2C). 
Because they were the predominant pluripotent populations, we compared expression of 
SSEA4− control cells (n=2 biological replicates) to SSEA4+ TFAP2C−/− cells (n=3 
biological replicates) d, To identify TFAP2C-dependent enhancers, we identified the overlap 
of the naïve-specific and TFAP2C ChIP-seq peaks, then took the subset of peaks that 
showed >50% density reduction in TFAP2C−/− SSEA4+ as compared with control SSEA4− 
cells, normalized for total read depth. These were classified as TFAP2C-dependent 
regulatory elements. e, ATAC-seq read density over all naïve-specific ATAC-peaks, naïve-
specific ATAC peaks overlapping with TFAP2C ChIP-seq peaks, and the TFAP2C-
dependent regulatory element set identified in (d). Note dramatic loss of signal in TFAP2C
−/−
 over the TFAP2C-dependent set. f, Frequency with which a gene a given distance from a 
Pastor et al. Page 30
Nat Cell Biol. Author manuscript; available in PMC 2018 October 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
TFAP2C-dependent ATAC-seq peak is positively or negatively regulated by TFAP2C. g, 
Distance of TFAP2C-dependent ATAC-seq peak to nearest gene. Note that the vast majority 
of such elements are enhancers. h, Schematic demonstrating the typical regulatory role of 
TFAP2C in naïve hESCs. Where TFAP2C facilitates the opening of a new enhancer, it has a 
positive regulatory role. Where it hones to chromatin that is already open, it has no tangible 
effect on transcription. i, ATAC-seq and ChIP-seq data are shown in the vicinity of naïve-
pluripotency factor TFCP2L1.
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Figure 8. A TFAP2C+ intronic enhancer of OCT4
a, Chromatin landscape of OCT4. Two putative enhancers “intron element 1” and “intron 
element 2” are present in blastocyst. Intron element 1 is also strongly enriched in naïve cells 
and lost in TFAP2C−/ −. b, The location of consensus motifs for key pre-implantation 
transcription factors is shown in the vicinity of Intron Elements 1 and 2. Note the clustering 
of AP2 sites at each element. The control low O2 track is the SSEA4− population, the 
TFAP2C−/− low O2 is the SSEA4+ population. The region targeted for CRISPR deletion is 
shown. c, ATAC-seq reads over the murine POU5F1 locus in naïve (2i+LIF) conditions. 
Note the absence of either intronic enhancer. d, Luciferase activity from a pGL3 construct in 
which WT or mutant Intron Element 1 had been cloned, normalized to signal from a pGL3 
construct with no enhancer. Results are shown from two independent experiment, except for 
the ΔAP2 sample, for which there are n=3 replicates from two experiments. All signals were 
first normalized for Renilla signal. e, OCT4 expression is lost over time upon reversion of 
the intron element 1-deleted mutant, indicating differentiation. Sorting for SSEA4− cells in 
5iLAF culture typically produces a pure population of naïve hESCs, but this population has 
lost OCT4 expression in the intron element 1-deleted mutant. Mean of n=2 technical 
replicates is shown. f, A line in which the intron element 1 is deleted appears normal in 
primed conditions but fails to yield naïve colonies upon reversion. Scale bar indicates 
200μm. Images are representative of 3 independent reversions. Source data for d is available 
in Supplementary Table 8.
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